Who needs venture capital? Not Stanford medical researchers whose work shows potential for clinical applications. Last month, Stanford University Hospital announced that it had awarded $351 ,200 to nine projects that need only to be developed a bit further to be ready for clinical testing. These are the first awards made by the hospital under its new technology transfer program, which was announced last summer. In an attempt to speed the transfer of innovative techniques from lab to bedside, the hospital has committed $1 ,750,OOO for three-and-a-half years to be used to encourage researchers to find clinical applications for their work. Among the projects that have received funds are a molecular probe for leukemia; a computer system that processes magnetoc resonance images for evaluating heart function and new technology for measuring respiratory functions in seriously ill infants. If these or other projects prove commercially viable, the hospital hopes to put...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?